MigraineScience

Discover key predictors of Aimovig (erenumab) response in migraine patients. This REFORM study reveals which patients benefit most from CGRP therapy and why timing matters. Evidence-based insights for better treatment...

STAR study shows atogepant (Qulipta) effectively reduces migraine days by 56.6% in real-world clinical practice, even for patients with previous treatment failures. Learn about this breakthrough.

Groundbreaking research reveals how migraine patients process visual information differently. This 2025 study found that migraine patients take longer to process simple visual stimuli compared to complex images, which is...

In a development for migraine patients, the FDA has granted marketing authorization to CT-132, making it the first prescription digital therapeutic specifically designed for the preventive treatment of episodic migraine...

This meta-analysis found that weather conditions, especially temperature and ambient pressure changes as well as increased levels of certain air pollutants (PM10, PM2.5, NO2, CO, and O3), are significantly associated...

Biofeedback is a non-invasive, non-pharmacological approach that enables individuals to gain control over physiological processes linked to migraine, such as muscle tension, blood flow, and brain activity. Using monitoring equipment,...

Chronic Pain Conditions Associated with Migraine Condition Description Association with Migraine References Irritable Bowel Syndrome (IBS) A functional gastrointestinal disorder characterized by abdominal pain and altered bowel habits. Higher prevalence...